全球醫療設備用覆膜市場

全球醫療設備用覆膜市場 是由出版商BCC Research在2008年11月所出版的。 這份英文市場調查報告書包含263 pages 價格從美金4850起跳。

簡介

目錄

Abstract

This report:

• Analyzes the markets for medical device coatings and surface treatment technologies worldwide, by medical specialty and material, with forecasts through 2013
• Examines the seven basic types of materials currently used to create coatings for more than 92,000 unique medical devices
• Explains how the successful commercialization of engineered alloys, ceramics and polymers has transformed coatings from passive to active components in medical devices
• Discusses changing medical needs that are accelerating the future demand for coated medical products
• Reviews patents and profiles key coating and medical device suppliers.

Table of Contents

Chapter- 1: SUMMARY 2

• SUMMARY TABLE GLOBAL MEDICAL DEVICE COATING MARKET, BY REGION, THROUGH 2014 ($ MILLIONS) 8
• SUMMARY FIGURE GLOBAL MEDICAL DEVICE COATING MARKET, BY REGION, 2009 AND 2014 ($ MILLIONS) 8

Chapter- 2: INDUSTRY OVERVIEW 7

• INDUSTRY OVERVIEW 9
• THE EVOLVING MEDICAL DEVICE COATING INDUSTRY 10
• INTERNATIONAL COOPERATION AND HARMONIZATION 11
• INTERNATIONAL STANDARDIZATION ORGANIZATION 12
• TABLE 1 ISO 10993 STANDARDS PERTAINING TO MEDICAL DEVICE COATINGS 13
• AMERICAN SOCIETY FOR TESTING AND MATERIALS 13
• TABLE 2 PROPOSED STANDARDS UNDER CONSIDERATION BY ASTM INTERNATIONAL COMMITTEE ON MEDICAL AND SURGICAL MATERIALS AND DEVICES 14
• TABLE 3 ASTM COATING-RELATED STANDARDS 14
• TABLE 3 (CONTINUED) 15

Chapter- 3: THE MEDICAL DEVICE COATINGS COMMUNITY 10

• NATIONALLY BASED ORGANIZATIONS 16
• Nationally Based Organizations (Continued) 17
• Nationally Based Organizations (Continued) 18
• THE CONTINUING IMPORTANCE OF ACADEMIC RESEARCH 19
• THE CONTINUING IMPORTANCE OF ・ ・ ・ ・ ・ ・ (CONTINUED) 20
• COATING PURCHASERS AND BUYING INFLUENCES 21
• CONTRACT MANUFACTURERS 22
• CONTRACT STERILIZERS 22
• DEVICE MANUFACTURERS 22
• FOREIGN EXPORTERS 22
• INITIAL DISTRIBUTORS 22
• RELABELERS 23
• REMANUFACTURERS 23
• REPACKAGERS 23
• REPROCESSORS OF SINGLE-USE DEVICES 23
• SPECIFICATION DEVELOPERS 23
• COATING SUPPLIERS 24
• COATING SUPPLIERS (CONTINUED) 25

Chapter- 4: THE FDA AND THE COATING INDUSTRY 11

• THE FDA AND THE COATING INDUSTRY 26
• CONTROL CLASS DESIGNATION 27
• CONTROL CLASS DESIGNATION (CONTINUED) 28
• CLASS I MEDICAL DEVICES 29
• CLASS II MEDICAL DEVICES 29
• CLASS III MEDICAL DEVICES 30
• COATINGS LEAD TO A NEW PRODUCT CATEGORY 31
• COATINGS LEAD TO A NEW ・ ・ ・ ・ ・ ・ (CONTINUED) 32
• FDA PANEL ASSIGNMENTS SEGMENT THE MARKET 33
• TABLE 4 MEDICAL DEVICES, BY TYPE AND VARIATION 34
• TABLE 4 (CONTINUED) 35
• COATING-RELATED RECALLS 35
• TABLE 5 FDA RECALLS INVOLVING COATINGS 35
• TABLE 5 (CONTINUED) 36

Chapter- 5: PATENT ANALYSIS 10

• TABLE 6 MEDICAL DEVICE COATING PATENTS ISSUED SINCE 1976 37
• TABLE 6 (CONTINUED) 38
• TABLE 6 (CONTINUED) 39
• TABLE 6 (CONTINUED) 40
• TABLE 6 (CONTINUED) 41
• TABLE 6 (CONTINUED) 42
• TABLE 6 (CONTINUED) 43
• TABLE 7 KEY DRUG-RELATED COATING PATENTS 44
• TABLE 8 HEPARIN-RELATED COATING PATENTS 44
• TABLE 8 (CONTINUED) 45
• TABLE 9 STENT-RELATED COATING PATENTS 45
• TABLE 9 (CONTINUED) 46

Chapter- 6: FACTORS DRIVING COATING DEMAND 8

• BOOMERS REACH MEDICARE AGE 47
• BOOMERS REACH MEDICARE AGE (CONTINUED) 48
• TABLE 10 GLOBAL GROWTH IN OLDER POPULATIONS (% OF POPULATION AGE 65 OR OLDER IN 2015) 49
• TABLE 11 MOST COMMON INPATIENT SURGICAL PROCEDURES FOR OLDER AMERICANS 50
• TABLE 11 (CONTINUED) 51
• TABLE 12 AVERAGE LENGTH OF HOSPITAL STAY BY SEX AND AGE (DAYS) 51
• THE MEDICARE NOSOCOMIAL INFECTION INITIATIVE 51
• THE MEDICARE NOSOCOMIAL ・ ・ ・ ・ ・ ・ (CONTINUED) 52
• UNCERTAIN IMPACT OF MEDICAL TOURISM ON COATINGS 53
• UNCERTAIN IMPACT OF MEDICAL ・ ・ ・ ・ ・ ・ (CONTINUED) 54

Chapter- 7: ASSESSING COATING REQUIREMENTS 7

• ASSESSING COATING REQUIREMENTS 55
• TABLE 13 THREE PERSPECTIVES ON THE COATINGS MARKET 56
• REGIONAL DEFINITIONS 56
• TABLE 14 GLOBAL REQUIREMENT FOR MEDICAL DEVICE COATINGS USED IN ALL MEDICAL SPECIALTIES, BY REGION, THROUGH 2014 ($ MILLIONS) 57
• FIGURE 1 GLOBAL REQUIREMENT FOR MEDICAL DEVICE COATINGS USED IN ALL MEDICAL SPECIALTIES, BY REGION, THROUGH 2014 ($ MILLIONS) 57
• NORTH AMERICAN FREE TRADE AGREEMENT COUNTRIES 58
• TABLE 15 NAFTA COUNTRIES 58
• EUROPEAN UNION 58
• TABLE 16 EUROPEAN UNION COUNTRIES 59
• OTHER DEVELOPED NATIONS 59
• TABLE 17 OTHER DEVELOPED COUNTRIES 60
• REST OF THE WORLD 60
• TABLE 18 REST OF THE WORLD 61

Chapter- 8: 2009 TO 2014 REQUIREMENT FORECASTS BY COATING TECHNOLOGY 45

• TABLE 19 REQUIREMENT FOR MEDICAL DEVICE COATINGS, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 62
• FIGURE 2 GLOBAL REQUIREMENT FOR COATING MATERIALS, 2014 ($ MILLIONS) 63
• TABLE 20 REQUIREMENT FOR ALL COATING TECHNOLOGIES, BY ALL MEDICAL SPECIALTIES, THROUGH 2014 ($ MILLIONS) 63
• TABLE 20 (CONTINUED) 64
• ALLOY COATING TECHNOLOGIES 64
• ALUMINUM 65
• GOLD 65
• NITINOL 66
• SILVER COMPOUNDS 66
• STAINLESS STEEL 67
• TITANIUM 68
• ZINC OXIDE 69
• GLOBAL REQUIREMENT FORECAST FOR ALLOY TECHNOLOGIES 69
• TABLE 21 REQUIREMENT FOR ALLOY COATING TECHNOLOGY, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 69
• TABLE 21 (CONTINUED) 70
• CERAMIC COATING TECHNOLOGIES 70
• ALUMINA 70
• BIOGLASS 71
• CARBON-BASED 72
• GLOBAL REQUIREMENT FORECAST FOR CERAMIC-BASED TECHNOLOGIES 73
• TABLE 22 REQUIREMENT FOR CERAMIC TECHNOLOGY COATINGS, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 73
• TABLE 22 (CONTINUED) 74
• COMBINATION PRODUCT COATING TECHNOLOGIES 74
• TABLE 23 ACTIVE AGENTS AND CARRIERS USED IN COMBINATION PRODUCT COATINGS 75
• MEDI-COAT CARRIER TECHNOLOGY 76
• BONE MORPHOGENETIC PROTEIN 2 76
• CATIONIC STEROID ANTIMICROBIALS 76
• COLLAGEN 77
• DEXAMETHASONE 77
• GORE/CARMEDA BIOACTIVE SURFACE TECHNOLOGY 77
• HEPARIN 78
• HYALURONAN 78
• HYDROGELS 79
• HYDROXYAPATITE 79
• NITRIC OXIDE 80
• PACLITAXEL 81
• PARYLENES (POLY-PARA-XYLENE) 81
• Parylenes (poly-para-xylene) (Continued) 82
• PHOSPHORYLCHOLINE (PC TECHNOLOGY) 83
• POLYMERDRUGS 83
• POLYETHYLENE 83
• Polyethylene (Continued) 84
• SIROLIMUS, EVEROLIMUS, AND ZOTAROLIMUS 85
• STEM CELL COATINGS 85
• GLOBAL REQUIREMENT FORECAST FOR COMBINATION PRODUCT TECHNOLOGIES 86
• TABLE 24 REQUIREMENT FOR COMBINATION PRODUCT TECHNOLOGIES, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 86
• TABLE 24 (CONTINUED) 87
• ENERGY-ABSORBING TECHNOLOGIES 87
• ENERGY-ABSORBING ・ ・ ・ ・ ・ ・ (CONTINUED) 88
• ENERGY-ABSORBING TECHNOLOGIES (CONTINUED) 89
• GLOBAL REQUIREMENT FORECAST FOR ENERGY-ABSORBING COATING TECHNOLOGIES 90
• TABLE 25 REQUIREMENT FOR ENERGY-ABSORBING TECHNOLOGY COATINGS, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 90
• ENERGY-EMITTING TECHNOLOGIES 91
• ENERGY-EMITTING ・ ・ ・ ・ ・ ・ (CONTINUED) 92
• GLOBAL REQUIREMENT FORECAST FOR ENERGY-EMITTING TECHNOLOGIES 93
• TABLE 26 REQUIREMENT FOR ENERGY-EMITTING TECHNOLOGIES, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 93
• TABLE 26 (CONTINUED) 94
• MICRO- AND NANO-COATINGS 94
• CONTINUING UNCERTAINTY ON HEALTH RISKS 95
• GLOBAL REQUIREMENT FORECAST FOR MICRO AND NANO TECHNOLOGIES 96
• TABLE 27 REQUIREMENT FOR MICRO- AND NANOTECHNOLOGY COATINGS, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 96
• TABLE 27 (CONTINUED) 97
• PROTECTIVE POLYMER COATINGS 97
• HEXYL-PVP 98
• PDMS POLY(DIMETHYL SILOXANE) 99
• POLYURETHANE 99
• PTFE POLYTETRAFLUOROETHYLENE TEFLON 99
• PVC POLYVINYL CHLORIDE 100
• GLOBAL REQUIREMENT FORECAST FOR PROTECTIVE POLYMER TECHNOLOGIES 100
• TABLE 28 REQUIREMENT FOR PROTECTIVE POLYMER TECHNOLOGIES, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 101
• SURFACE TREATMENT TECHNOLOGIES 102
• DIRECT DEPOSITION TECHNIQUES 102
• PLASMA TECHNIQUES 102
• ION IMPLANTATION TECHNIQUES 103
• LASER ACTIVATION 104
• TEXTURING 104
• GLOBAL REQUIREMENT FORECAST FOR SURFACE TREATMENT TECHNOLOGIES 105
• TABLE 29 GLOBAL REQUIREMENT FOR SURFACE TREATMENT TECHNOLOGIES, BY MEDICAL SPECIALTY, THROUGH 2014 ($ MILLIONS) 105
• TABLE 29 (CONTINUED) 106

Chapter- 9: 2009 TO 2014 REQUIREMENT FORECASTS BY MEDICAL SPECIALTY 91 $2517

• TABLE 30 FACTORS INFLUENCING THE REQUIREMENT FOR NEW COATINGS 107
• TABLE 30 (CONTINUED) 108
• ANESTHESIA DEVICE COATING REQUIREMENTS 109
• TABLE 31 ANESTHESIA DIAGNOSTIC DEVICES 109
• TABLE 31 (CONTINUED) 110
• TABLE 32 ANESTHESIA MONITORING DEVICES 110
• TABLE 32 (CONTINUED) 111
• TABLE 33 THERAPEUTIC ANESTHESIA DEVICES 111
• TABLE 33 (CONTINUED) 112
• TABLE 34 MISCELLANEOUS ANESTHESIA DEVICES 113
• TECHNOLOGY REQUIREMENT FOR ANESTHESIA DEVICE COATINGS 113
• TABLE 35 GLOBAL COATING REQUIREMENTS FOR ANESTHESIA DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 113
• REGIONAL REQUIREMENT FOR ANESTHESIA DEVICE COATINGS 114
• TABLE 36 REGIONAL COATING REQUIREMENTS FOR ANESTHESIA DEVICES ($ MILLIONS) 114
• CARDIOVASCULAR MEDICINE 114
• CARDIOVASCULAR MEDICINE (CONTINUED) 115
• CARDIOVASCULAR MEDICINE (CONTINUED) 116
• TABLE 37 CARDIOVASCULAR DIAGNOSTIC DEVICES 117
• TABLE 38 CARDIOVASCULAR MONITORING DEVICES 118
• TABLE 39 CARDIOVASCULAR PROSTHETIC DEVICES 119
• TABLE 40 CARDIOVASCULAR SURGICAL DEVICES 119
• TABLE 40 (CONTINUED) 120
• TABLE 41 CARDIOVASCULAR THERAPEUTIC DEVICES 120
• TECHNOLOGY REQUIREMENT FOR CARDIOVASCULAR DEVICE COATINGS 121
• TABLE 42 GLOBAL COATING REQUIREMENTS FOR CARDIOVASCULAR DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 121
• REGIONAL REQUIREMENT FOR CARDIOVASCULAR DEVICE COATINGS 121
• TABLE 43 REGIONAL COATING REQUIREMENTS FOR CARDIOVASCULAR DEVICES, THROUGH 2014 ($ MILLIONS) 122
• CLINICAL MEDICINE 122
• TABLE 44 CLINICAL CHEMISTRY TEST SYSTEMS 122
• TABLE 44 (CONTINUED) 123
• TABLE 44 (CONTINUED) 124
• TABLE 44 (CONTINUED) 125
• TABLE 44 (CONTINUED) 126
• TABLE 45 CLINICAL LABORATORY INSTRUMENTS 126
• TECHNOLOGY REQUIREMENTS FOR CLINICAL CHEMISTRY DEVICE COATINGS 127
• TABLE 46 GLOBAL COATING REQUIREMENTS FOR CLINICAL MEDICINE DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 127
• REGIONAL REQUIREMENT FOR CLINICAL MEDICINE DEVICE COATINGS 127
• TABLE 47 REGIONAL COATING REQUIREMENTS FOR CLINICAL MEDICINE DEVICES, THROUGH 2014 ($ MILLIONS) 128
• CLINICAL TOXICOLOGY 128
• TABLE 48 CLINICAL TOXICOLOGY TEST SYSTEMS 128
• TABLE 48 (CONTINUED) 129
• TECHNOLOGY REQUIREMENTS FOR CLINICAL TOXICOLOGY DEVICE COATINGS 129
• TABLE 49 GLOBAL COATING REQUIREMENTS FOR CLINICAL TOXICOLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 130
• REGIONAL REQUIREMENTS FOR CLINICAL TOXICOLOGY DEVICE COATINGS 130
• TABLE 50 REGIONAL COATING REQUIREMENTS FOR CLINICAL TOXICOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 130
• DENTISTRY 131
• TABLE 51 DENTAL DIAGNOSTIC DEVICES 132
• TABLE 52 DENTAL PROSTHETIC DEVICES 132
• TABLE 52 (CONTINUED) 133
• TABLE 53 DENTAL SURGICAL DEVICES 134
• TABLE 54 DENTAL THERAPEUTIC DEVICES 134
• TABLE 55 MISCELLANEOUS DENTAL DEVICES 134
• TABLE 55 (CONTINUED) 135
• TECHNOLOGY REQUIREMENT FOR DENTAL DEVICE COATINGS 135
• TABLE 56 GLOBAL COATING REQUIREMENT FOR DENTAL DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 136
• REGIONAL REQUIREMENT FOR DENTAL DEVICE COATINGS 136
• TABLE 57 REGIONAL COATING REQUIREMENTS FOR DENTAL DEVICES, THROUGH 2014 ($ MILLIONS) 136
• EAR, NOSE, AND THROAT 137
• TABLE 58 EAR, NOSE, AND THROAT DIAGNOSTIC DEVICES 137
• TABLE 59 EAR, NOSE, AND THROAT PROSTHETIC DEVICES 137
• TABLE 60 EAR, NOSE, AND THROAT SURGICAL DEVICES 138
• TABLE 61 EAR, NOSE, AND THROAT THERAPEUTIC DEVICES 138
• TECHNICAL REQUIREMENTS FOR COATINGS FOR MEDICAL DEVICES USED BY EAR, NOSE, AND THROAT SPECIALISTS 138
• TABLE 62 GLOBAL COATING REQUIREMENT FOR EAR, NOSE, AND THROAT DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 139
• REGIONAL REQUIREMENTS FOR COATINGS FOR MEDICAL DEVICES USED BY EAR, NOSE, AND THROAT SPECIALISTS 139
• TABLE 63 GLOBAL COATING REQUIREMENT FOR EAR, NOSE, AND THROAT DEVICES, BY REGION, THROUGH 2014 ($ MILLIONS) 139
• GASTROENTEROLOGY 140
• TABLE 64 GASTROENTEROLOGY DIAGNOSTIC DEVICES 140
• TABLE 65 GASTROENTEROLOGY-UROLOGY SURGICAL DEVICES 140
• TABLE 66 GASTROENTEROLOGY-UROLOGY THERAPEUTIC DEVICES 141
• TECHNOLOGY REQUIREMENTS FOR COATINGS FOR GASTROENTERIC DEVICES 141
• TABLE 67 GLOBAL COATING REQUIREMENT FOR GASTROENTEROLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 142
• REGIONAL REQUIREMENTS FOR COATINGS FOR GASTROENTERIC DEVICES 142
• TABLE 68 REGIONAL COATING REQUIREMENT FOR GASTROENTEROLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 142
• GENERAL AND PLASTIC SURGERY 143
• TABLE 69 SURGICAL DEVICES 144
• TABLE 69 (CONTINUED) 145
• TECHNOLOGY REQUIREMENTS FOR SURGICAL DEVICE COATINGS 145
• TABLE 70 GLOBAL COATING REQUIREMENT FOR GENERAL AND PLASTIC SURGERY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 145
• REGIONAL REQUIREMENTS FOR SURGICAL DEVICE COATINGS 145
• TABLE 71 REGIONAL COATING REQUIREMENT FOR GENERAL AND PLASTIC SURGERY DEVICES, THROUGH 2014 ($ MILLIONS) 146
• GENERAL HOSPITAL USE DEVICES 146
• TABLE 72 MONITORING DEVICES FOR GENERAL HOSPITAL USE 147
• TABLE 73 THERAPEUTIC DEVICES FOR GENERAL HOSPITAL USE 147
• TABLE 73 (CONTINUED) 148
• TABLE 74 MISCELLANEOUS MEDICAL DEVICES FOR GENERAL HOSPITAL USE 148
• TABLE 74 (CONTINUED) 149
• TECHNOLOGY REQUIREMENTS FOR GENERAL HOSPITAL MEDICAL DEVICE COATINGS 149
• TABLE 75 GLOBAL COATING REQUIREMENTS FOR GENERAL HOSPITAL DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 150
• REGIONAL REQUIREMENTS FOR GENERAL HOSPITAL MEDICAL DEVICE COATINGS 150
• TABLE 76 REGIONAL COATING REQUIREMENTS FOR GENERAL HOSPITAL DEVICES, THROUGH 2014 ($ MILLIONS) 150
• HEMATOLOGY 151
• TABLE 77 HEMATOLOGY INSTRUMENTATION 151
• TABLE 78 AUTOMATED AND SEMI-AUTOMATED HEMATOLOGY DEVICES 151
• TABLE 79 MANUAL HEMATOLOGY DEVICES 152
• TABLE 80 BLOOD BANK SUPPLIES 152
• TECHNOLOGY REQUIREMENTS FOR COATINGS FOR HEMATOLOGY DEVICES 152
• TABLE 81 GLOBAL COATING REQUIREMENTS FOR HEMATOLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 153
• REGIONAL REQUIREMENTS FOR COATINGS FOR HEMATOLOGY DEVICES 153
• TABLE 82 REGIONAL COATING REQUIREMENTS FOR HEMATOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 153
• IMMUNOLOGY 154
• TABLE 83 IMMUNOLOGY LABORATORY EQUIPMENT AND REAGENTS 154
• TABLE 84 TUMOR ASSOCIATED ANTIGEN IMMUNOLOGICAL TEST SYSTEMS 154
• TECHNOLOGY REQUIREMENTS FOR COATINGS FOR IMMUNOLOGICAL DEVICES 154
• TABLE 85 GLOBAL COATING REQUIREMENT FOR IMMUNOLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 155
• REGIONAL REQUIREMENT FOR COATINGS FOR IMMUNOLOGICAL DEVICES 155
• TABLE 86 REGIONAL COATING REQUIREMENT FOR IMMUNOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 155
• MICROBIOLOGY 156
• TABLE 87 DEVICES USED IN MICROBIOLOGY DEVICES 156
• TECHNOLOGY REQUIREMENTS FOR MICROBIOLOGY DEVICE COATINGS 156
• TABLE 88 GLOBAL COATING REQUIREMENT FOR DEVICES USED IN MICROBIOLOGY, THROUGH 2014 ($ MILLIONS) 157
• TECHNOLOGY REQUIREMENTS FOR MICROBIOLOGY DEVICE COATINGS 157
• TABLE 89 REGIONAL COATING REQUIREMENTS FOR DEVICES USED IN MICROBIOLOGY, THROUGH 2014 ($ MILLIONS) 157
• NEUROLOGY 158
• NEUROLOGY (CONTINUED) 159
• TABLE 90 NEUROLOGICAL DIAGNOSTIC DEVICES 160
• TABLE 91 NEUROLOGICAL SURGICAL DEVICES 160
• TABLE 92 NEUROLOGICAL THERAPEUTIC DEVICES 161
• TECHNOLOGY REQUIREMENTS FOR NEUROLOGICAL DEVICE COATINGS 161
• TABLE 93 GLOBAL COATING REQUIREMENTS FOR NEUROLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 162
• REGIONAL TECHNOLOGY REQUIREMENT FOR NEUROLOGICAL DEVICE COATINGS 162
• TABLE 94 REGIONAL COATING REQUIREMENTS FOR NEUROLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 162
• OBSTETRICS AND GYNECOLOGY 163
• TABLE 95 OBSTETRICAL AND GYNECOLOGICAL DIAGNOSTIC DEVICES 163
• TABLE 96 OBSTETRICAL AND GYNECOLOGICAL MONITORING DEVICES 163
• TABLE 97 OBSTETRICAL AND GYNECOLOGICAL PROSTHETIC DEVICES 164
• TABLE 98 OBSTETRICAL AND GYNECOLOGICAL SURGICAL DEVICES 164
• TABLE 99 OBSTETRICAL AND GYNECOLOGICAL THERAPEUTIC DEVICES 164
• TABLE 100 ASSISTED REPRODUCTION DEVICES 165
• TECHNOLOGY REQUIREMENTS FOR OBSTETRICAL AND GYNECOLOGICAL DEVICE COATINGS 165
• TABLE 101 COATING REQUIREMENT FOR OBSTETRICS AND GYNECOLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 165
• REGIONAL REQUIREMENTS FOR OBSTETRICAL AND GYNECOLOGICAL DEVICE COATINGS 166
• TABLE 102 REGIONAL COATING REQUIREMENT FOR OBSTETRICS AND GYNECOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 166
• OPHTHALMOLOGY 166
• TABLE 103 OPHTHALMIC DIAGNOSTIC DEVICES 167
• TABLE 103 (CONTINUED) 168
• TABLE 104 OPHTHALMIC PROSTHETIC DEVICES 168
• TABLE 105 OPHTHALMIC SURGICAL DEVICES 168
• TABLE 105 (CONTINUED) 169
• TABLE 106 OPHTHALMIC THERAPEUTIC DEVICES 169
• TECHNOLOGY REQUIREMENTS FOR OPHTHALMIC DEVICE COATINGS 169
• TABLE 107 GLOBAL COATING REQUIREMENT FOR OPHTHALMOLOGY, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 170
• REGION TECHNOLOGY REQUIREMENTS FOR OPHTHALMIC DEVICE COATINGS 170
• TABLE 108 REGIONAL COATING REQUIREMENTS FOR OPHTHALMOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 170
• ORTHOPEDICS 171
• ORTHOPEDICS (CONTINUED) 172
• TABLE 109 ORTHOPEDIC DIAGNOSTIC DEVICES 173
• TABLE 110 ORTHOPEDIC PROSTHETIC DEVICES 173
• TABLE 110 (CONTINUED) 174
• TABLE 110 (CONTINUED) 175
• TABLE 111 ORTHOPEDIC SURGICAL DEVICES 175
• TECHNOLOGY REQUIREMENTS FOR ORTHOPEDIC DEVICE COATINGS 175
• TABLE 112 GLOBAL COATING REQUIREMENTS FOR ORTHOPEDICS DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 176
• REGIONAL REQUIREMENTS FOR ORTHOPEDIC DEVICE COATINGS 176
• TABLE 113 REGIONAL COATING REQUIREMENTS FOR ORTHOPEDICS DEVICES, THROUGH 2014 ($ MILLIONS) 176
• PATHOLOGY 177
• TABLE 114 PATHOLOGY INSTRUMENTATION 177
• TABLE 115 AUTOMATED AND SEMI-AUTOMATED PATHOLOGY DEVICES 177
• TABLE 116 MANUAL PATHOLOGY DEVICES 178
• TECHNOLOGY REQUIREMENTS FOR PATHOLOGY DEVICE COATINGS 178
• TABLE 117 GLOBAL COATING REQUIREMENTS FOR PATHOLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 178
• REGIONAL TECHNOLOGY REQUIREMENTS FOR PATHOLOGY DEVICE COATINGS 179
• TABLE 118 REGIONAL COATING REQUIREMENTS FOR PATHOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 179
• PERSONAL USE 179
• TABLE 119 PERSONAL USE MONITORING DEVICES 180
• TABLE 120 PERSONAL USE THERAPEUTIC DEVICES 180
• TABLE 121 MISCELLANEOUS PERSONAL USE MEDICAL DEVICES 181
• TECHNOLOGY REQUIREMENTS FOR PERSONAL USE DEVICE COATINGS 181
• TABLE 122 GLOBAL COATING REQUIREMENTS FOR PERSONAL USE DEVICES, BY TECHNOLOGY. THROUGH 2014 ($ MILLIONS) 182
• REGIONAL REQUIREMENTS FOR PERSONAL USE DEVICE COATINGS 182
• TABLE 123 REGIONAL COATING REQUIREMENTS FOR PERSONAL USE DEVICES, THROUGH 2014 ($ MILLIONS) 182
• PHYSICAL MEDICINE 183
• TABLE 124 PHYSICAL MEDICINE DIAGNOSTIC DEVICES 183
• TABLE 125 PHYSICAL MEDICINE PROSTHETIC DEVICES 183
• TABLE 126 PHYSICAL MEDICINE THERAPEUTIC DEVICES 184
• TECHNOLOGY REQUIREMENTS FOR PHYSICAL MEDICINE DEVICE COATINGS 184
• TABLE 127 GLOBAL COATING REQUIREMENTS FOR PHYSICAL MEDICINE DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 185
• REGIONAL REQUIREMENTS FOR PHYSICAL MEDICINE DEVICE COATINGS 185
• TABLE 128 REGIONAL COATING REQUIREMENTS FOR PHYSICAL MEDICINE DEVICES, THROUGH 2014 ($ MILLIONS) 185
• RADIOLOGY 186
• TABLE 129 RADIOLOGY DIAGNOSTIC DEVICES 186
• TABLE 129 (CONTINUED) 187
• TABLE 130 RADIOGRAPHIC THERAPEUTIC DEVICES 187
• TABLE 130 (CONTINUED) 188
• TECHNICAL REQUIREMENTS FOR RADIOLOGY DEVICE COATINGS 188
• TABLE 131 GLOBAL COATING REQUIREMENTS FOR RADIOLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 188
• REGIONAL REQUIREMENT FOR RADIOLOGY DEVICE COATINGS 188
• TABLE 132 REGIONAL COATING REQUIREMENT FOR RADIOLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 189
• RESPIRATORY THERAPY 189
• TABLE 133 RESPIRATORY DIAGNOSTIC DEVICES 189
• TABLE 133 (CONTINUED) 190
• TABLE 134 RESPIRATORY MONITORING DEVICES 190
• TABLE 134 (CONTINUED) 191
• TABLE 135 THERAPEUTIC RESPIRATORY DEVICES 191
• TABLE 135 (CONTINUED) 192
• TABLE 136 MISCELLANEOUS RESPIRATORY DEVICES 192
• TECHNICAL REQUIREMENTS FOR RESPIRATORY DEVICE COATINGS 193
• TABLE 137 GLOBAL COATING REQUIREMENTS FOR RESPIRATORY THERAPY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 193
• REGIONAL REQUIREMENTS FOR RESPIRATORY DEVICE COATINGS 193
• TABLE 138 REGIONAL COATING REQUIREMENTS FOR RESPIRATORY THERAPY DEVICES, THROUGH 2014 ($ MILLIONS) 194
• UROLOGY 194
• TABLE 139 UROLOGY DIAGNOSTIC DEVICES 194
• TABLE 140 UROLOGY PROSTHETIC DEVICES 195
• TABLE 141 UROLOGY SURGICAL DEVICES 195
• TABLE 142 UROLOGY THERAPEUTIC DEVICES 195
• TABLE 142 (CONTINUED) 196
• TECHNOLOGY REQUIREMENTS FOR UROLOGY DEVICE COATINGS 196
• TABLE 143 GLOBAL COATING REQUIREMENTS FOR UROLOGY DEVICES, BY TECHNOLOGY, THROUGH 2014 ($ MILLIONS) 196
• REGIONAL REQUIREMENTS FOR UROLOGY DEVICE COATINGS 197
• TABLE 144 REGIONAL COATING REQUIREMENTS FOR UROLOGY DEVICES, THROUGH 2014 ($ MILLIONS) 197

Chapter- 10: APPENDIX: BUSINESSES WITH SIGNIFICANT INDUSTRY INVOLVEMENT 72 $1992

APPENDIX A: BUSINESSES WITH SIGNIFICANT INDUSTRY INVOLVEMENT 198

• 4TH STATE 198
• ABBOTT LABORATORIES 198
• ACCORD BIOMATERIALS 198
• ACRYMED 198
• ADHESIVE CONSULTANTS 199
• ADVANCED MEDICAL OPTICS 199
• ADVANSOURCE BIOMATERIALS 199
• AEONCLAD COATING 200
• AFFINERGY 200
• AGION TECHNOLOGIES 200
• ALCON 200
• ALL-CHEMIE 201
• ALLVIVO VASCULAR 201
• ANGIOTECH PHARMACEUTICALS 201
• ARMOLOY OF CONNECTICUT 202
• AST PRODUCTS 202
• BACTERIN INTERNATIONAL 202
• BAXTER HEALTHCARE 202
• BIOCOAT 203
• BIOCOMPATIBLES INTERNATIONAL 203
• BIOMET 203
• BIOPHAN 204
• BOSTON SCIENTIFIC 204
• BRISTOL-MYERS SQUIBB 204
• CARDIOTECH INTERNATIONAL 205
• CARMEDA 205
• CERAC 205
• CERAGENIX PHARMACEUTICALS 206
• CONOR MEDSYSTEMS 206
• CORDIS 206
• CORIN GROUP 207
• COVALON 207
• CURTISS-WRIGHT METAL TREATMENT 207
• CV THERAPEUTICS 208
• DEPUY ORTHOPAEDICS 208
• EDWARDS LIFESCIENCES 208
• HEMOTEQ 208
• HYDROMER 209
• I-FLOW 209
• JAPAN MEDICAL MATERIALS 209
• JOHNSON & JOHNSON 210
• LOMBARD MEDICAL TECHNOLOGIES 210
• MC3 210
• MEDTRONIC CARDIOVASCULAR 211
• MICRUS ENDOVASCULAR 211
• MIV THERAPEUTICS 211
• NANOCOPOEIA 212
• NERITES 212
• NIPPON ELECTRIC GLASS 212
• NOVARTIS PHARMA 213
• NUCRYST PHARMACEUTICALS 213
• PARA TECH COATING 213
• PARYLENE COATING SERVICES 213
• POLYMERIX 214
• SMITH & NEPHEW 214
• SONO-TEK 214
• SPECIALTY COATING SYSTEMS 214
• SPIRE 215
• ST. JUDE MEDICAL 215
• STRYKER 215
• SURFACE SOLUTIONS LABS 216
• SURMODICS 216
• TECHNI-MET 217
• THORATEC 217
• TYRX PHARMA 217
• WRIGHT MEDICAL TECHNOLOGY 218
• WYETH 218
• ZEBRA TECHNOLOGIES 218
• ZIMMER HOLDINGS 219

APPENDIX B: ABSTRACTS OF KEY COATING PATENTS 220

• ADHERENT FLEXIBLE HYDROGEL AND MEDICATED COATINGS 220
• AMINOGUANIDINYL- AND ALKOXYGUANIDINYL-SUBSTITUTED PHENYL ACETAMIDES AS PROTEASE INHIBITORS 220
• AN APPARATUS FOR COATING TUBULAR MEMBERS 221
• ANGIOTENSIN-(1-7) ELUTING POLYMER-COATED MEDICAL DEVICE TO REDUCE RESTENOSIS 221
• ANTIBIOTIC BONDING OF VASCULAR PROSTHESES AND OTHER IMPLANTS 221
• ANTI-INFECTIVE COVERING FOR PERCUTANEOUS AND VASCULAR ACCESS DEVICE AND COATING METHOD 222
• ANTITHROMBOGENIC MEMBRANE MIMETIC COMPOSITIONS AND METHODS 222
• ANTITHROMBOGENIC RETENTIVE CATHETER 222
• APPARATUS AND METHOD FOR ELECTROSTATIC SPRAY COATING OF MEDICAL DEVICES 223
• APPARATUS AND PROCESS FOR COATING ARTICLES 223
• APPARATUS AND METHOD FOR COATING IMPLANTABLE DEVICES 223
• BACTERICIDAL COATINGS FOR IMPLANTS 224
• BI-LAMINAR, HYALURONAN COATINGS WITH SILVER-BASED ANTIMICROBIAL PROPERTIES 224
• BIOCOMPATIBLE CARRIER CONTAINING ACTINOMYCIN D 224
• CERAMIC CARDIAC ELECTRODES 225
• BIOACTIVE AGENT-RELEASE COATING 225
• BIOMEDICAL MATERIAL FOR IMPROVING THE ADHESION AND PROLIFERATION OF CELLS AND A MODIFIED ARTIFICIAL VESSEL 225
• BIOACTIVE COATING COMPOSITION AND METHODS 226
• BIOABSORBABLE BRACHYTHERAPY DEVICE 226
• BIOPROSTHETIC HEART VALVES WITH HIGH CALCIFICATION RESISTANCE 227
• BIOSTATIC COATINGS FOR THE REDUCTION AND PREVENTION OF BACTERIAL ADHESION 227
• BLOOD CIRCULATION APPARATUS COUPLING DEVICE THAT IMPROVES BIOCOMPATIBILITY OF INNER SURFACES WITH TREATED BLOOD 227
• METHODS AND IMPLANTS FOR PROVIDING RADIATION TO A PATIENT 228
• COATED ORTHOPEDIC IMPLANT COMPONENTS 228
• COLLAGEN-IMPREGNATED DACRON GRAFT 228
• COATED ENDOVASCULAR STENT 229
• COATING DISPENSING SYSTEM AND METHOD USING A SOLENOID HEAD FOR COATING MEDICAL DEVICES 229
• COATING INTRALUMINAL STENTS 229
• COATED ORTHOPEDIC IMPLANT COMPONENTS 230
• COMPOSITION COMPRISING HEPARIN AS A NONTHROMBOGENIC SURFACE COATING AGENT 230
• COMPOSITION FOR COATING AN IMPLANTABLE PROSTHESIS 230
• CORONARY STENT WITH A RADIOACTIVE RADIOPAQUE COATING 231
• DEVICE AND PROCESS FOR COATING STENTS 231
• DEVICE FOR PROTECTING MEDICAL DEVICES DURING A COATING PROCESS 231
• DRUG-RELEASE STENT COATING PROCESS 232
• DRUG-POLYMER-COATED STENT WITH PEGYLATED STYRENIC BLOCK COPOLYMERS 232
• ECHOGENIC COATINGS 232
• EPTFE SMALL CALIBER VASCULAR GRAFTS WITH SIGNIFICANT PATENCY ENHANCEMENT VIA A SURFACE COATING WHICH CONTAINS COVALENTLY BONDED HEPARIN 233
• ETHYLENE VINYL ALCOHOL-DIMETHYL ACETAMIDE COMPOSITION AND A METHOD OF COATING A STENT 233
• FIBRIN-COATED POLYMER SURFACES 233
• FLUORINATING POLYMER SURFACES 234
• FUNCTIONALIZED POLYURETHANES 234
• GLAUCOMA SHUNT AND A METHOD OF MAKING AND SURGICALLY IMPLANTING OF SAME 234
• GRAFT POLYMERIZATION OF SUBSTRATE SURFACES 235
• GRAFTING OF BIOCOMPATIBLE HYDROPHILIC POLYMERS ONTO INORGANIC AND METAL SURFACES 235
• HEMOCOMPATIBLE COATINGS ON HYDROPHOBIC POROUS POLYMERS 235
• HEPARIN DELIVERY METHOD 236
• HIGHLY CROSSLINKED, EXTREMELY HYDROPHOBIC NITRIC OXIDE-RELEASING POLYMERS 236
• HYDROPHILIC POLYVINYLBUTYRAL ALLOYS 237
• HYDROPHILIC POLYMER BLEND 237
• INTRAVASCULAR STENT AND METHOD 237
• LOCAL DRUG DELIVERY 238
• LUBRICIOUS HYDROPHILIC COATING FOR AN INTRACORPOREAL MEDICAL DEVICE 238
• MECHANICAL AND ACOUSTICAL SUSPENSION COATING OF MEDICAL IMPLANTS 239
• MEDICAL DEVICE WITH SURFACE MODIFICATION WITH SUPEROXIDE DISMUTASE MIMIC 239
• MEDICAL DEVICES WITH DURABLE AND LUBRICIOUS POLYMERIC COATING 239
• METHOD AND APPARATUS FOR POLYMER APPLICATION TO INTRACORPOREAL DEVICE 240
• METHOD FOR ATTACHMENT OF BIOMOLECULES TO MEDICAL DEVICE SURFACES 240
• METHOD FOR COATING AN IMPLANTABLE DEVICE AND SYSTEM FOR PERFORMING THE METHOD 241
• METHOD FOR COATING IMPLANTABLE DEVICES 241
• METHOD FOR DELIVERING A THERAPEUTIC SUBSTANCE TO A BODY LUMEN 241
• METHOD FOR ETCHING A MICROPATTERNED MICRODEPOT PROSTHESIS 242
• METHOD AND APPARATUS FOR COATING AN IMPLANTABLE DEVICE 242
• METHODS OF COATING AN IMPLANTABLE DEVICE HAVING DEPOTS FORMED IN A SURFACE THEREOF 242
• METHOD OF FORMING A THERAPEUTIC COATING ONTO A SURFACE OF AN IMPLANTABLE PROSTHESIS 243
• MEDICAL DEVICE HAVING SURFACE MODIFICATION WITH SUPEROXIDE DISMUTASE MIMIC 243
• METHODS FOR COATING IMPLANTS 243
• METHOD OF IMPROVING THE BIOCOMPATIBILITY OF SYNTHETIC POLYMERS 244
• METHOD OF REDUCING PROTEIN DEPOSITION IN SIGHT CORRECTION DEVICES 244
• METHODS AND CLINICAL DEVICES FOR THE INHIBITION OR PREVENTION OF MAMMALIAN CELL GROWTH 244
• METHOD FOR FINE BORE ORIFICE SPRAY COATING OF MEDICAL DEVICES AND PREFILMING ATOMIZATION 245
• METHOD FOR IMPARTING A BIOACTIVE COATING 245
• METHOD FOR MAKING AND MEASURING A COATING ON THE SURFACE OF A MEDICAL DEVICE USING AN ULTRAVIOLET LASER 245
• METHOD FOR MANUFACTURING MEDICAL ARTICLES COMPOSED OF SILICONE RUBBER COATED WITH COLLAGEN 246
• METHOD FOR GROWING AN ALUMINA SURFACE ON ORTHOPAEDIC IMPLANT COMPONENTS 246
• METHOD OF FABRICATING A BIOCOMPATIBLE STENT 247
• METHOD FOR MICROPOROUS SURFACE MODIFICATION OF IMPLANTABLE METALLIC MEDICAL ARTICLES 247
• METHOD FOR PRETREATING THE SURFACE OF A MEDICAL DEVICE 247
• METHOD FOR ROLL COATING MULTIPLE STENTS 248
• METHOD FOR SPRAY COATING A MEDICAL DEVICE HAVING A TUBULAR WALL SUCH AS A STENT 248
• METHOD FOR SPRAY COATING MEDICAL DEVICES 249
• METHOD FOR SPRAY-COATING A MEDICAL DEVICE HAVING A TUBULAR WALL SUCH AS A STENT 249
• METHOD FOR TREATING MEDICAL DEVICES USING GLYCEROL AND AN ANTIMICROBIAL AGENT 250
• METHOD OF MAKING ANTIMICROBIAL POLYMERIC SURFACES 250
• METHOD TO STABILIZE TDMAC HEPARIN COATING 250
• METHODS FOR POLYMERIC COATINGS STENTS 251
• METHODS FOR SURFACE MODIFICATION 251
• METHODS OF FORMING A COATING FOR A PROSTHESIS 251
• METHODS OF POLYMER IMPREGNATION 252
• MICROPOROUS COVERED STENTS AND METHOD OF COATING 252
• NONIRRITATING ANTIMICROBIAL COATING FOR MEDICAL IMPLANTS 252
• NUCLEIC ACID COATING COMPOSITIONS AND METHODS 253
• OPTIMIZED DOSING FOR DRUG COATED STENTS 253
• PALLADIUM-COATED IMPLANT 253
• PHOTOACTIVATABLE NUCLEIC ACIDS 254
• PHYSICAL VAPOR DEPOSITION OF RADIOPAQUE MARKINGS ON A GRAFT 254
• STERILIZATION OF BIOACTIVE COATINGS 254
• PLASMA-CROSSLINKED HYDROPHILIC COATING 255
• POROUS PROSTHESIS AND A METHOD OF DEPOSITING SUBSTANCES INTO THE PORES 255
• POLYBIFUNCTIONAL REAGENT WITH A POLYMERIC BACKBONE AND LATENT REACTIVE MOIETIES AND BIOACTIVE GROUPS 256
• POLYCARBONATE-POLYURETHANE DISPERSIONS FOR THROMBO-RESISTANT COATINGS 256
• POLYMER-COATED STENT STRUCTURE 256
• POLYMERIC COATINGS CONTAINING A PH BUFFER AGENT 257
• POLYURETHANES GRAFTED WITH POLYETHYLENE OXIDE CHAINS CONTAINING COVALENTLY BONDED HEPARIN 257
• PREPARATION OF OPHTHALMIC COMPOSITIONS 257
• PROCESS FOR COATING A SURFACE OF A METALLIC STENT 258
• PROCESS FOR COATING A SURFACE OF A STENT 258
• PROCESS FOR COATING A SURFACE OF A STENT 259
• PROCESS FOR IMPREGNATING A POROUS MATERIAL WITH A CROSSLINKABLE COMPOSITION 259
• PROCESS FOR PREPARING SURFACE MODIFICATION SUBSTANCES 259
• RADIOACTIVE BALLOON FOR DILATION CATHETER SYSTEM AND PROCESS FOR PREPARATION 260
• RADIOACTIVE MEDICAL DEVICES 260
• RADIOACTIVE SEED IMPLANTS 260
• RESIN COMPOSITION AND MANUFACTURING METHOD 261
• SELECTIVE COATING OF MEDICAL DEVICES 261
• SEMIAUTOMATIC COATING SYSTEM METHODS FOR COATING MEDICAL DEVICES 261
• SILYL AND HEPARIN COMPOSITIONS 262
• SOFT X-RAY EMITTING RADIOACTIVE STENT 262
• STENT COATING DEVICE 262
• STENT COATING 263
• STENT WITH ANTITHROMBOGENIC COATING 263
• STENT WITH RADIOPAQUE COATING CONSISTING OF PARTICLES IN A BINDER 263
• SURFACE COATING AGENTS 264
• SURFACE FEATURES OF AN IMPLANTABLE MEDICAL DEVICE 264
• SURGICAL LUBRICANTS 265
• THERAPEUTIC USE OF POLYMERS 265
• THERAPEUTIC, DIAGNOSTIC, OR HYDROPHILIC COATING FOR AN INTRACORPOREAL MEDICAL DEVICE 265
• THROMBO-RESISTANT NONTHROMBOGENIC OBJECTS FORMED FROM RESIN-GRAPHITE MIXTURES 266
• TRIGGERED RELEASE HYDROGEL DRUG-DELIVERY SYSTEM 266
• VARIABLE SURFACE AREA STENT 267
• VASCULAR BIOMATERIAL DEVICES 267
• VASCULAR BIOMATERIAL 267
• VASCULAR PROSTHESIS AND METHOD OF MAKING THE SAME 268
• VASCULAR PROSTHESIS HAVING A COMPOSITE STRUCTURE 268
• WATER-SOLUBLE COATING AGENTS BEARING INITIATOR GROUPS 268
• ZWITTERIONIC MATERIALS 269
• ZWITTERIONIC POLYMER BLEND MATERIALS 269
• ZWITTERIONIC POLYMERS 269

相關商品

矚目市場調查報告書

全套市場調查報告定期訂閱

Market Research Report Subscription

BCC Research發行的醫療設備相關市場調查報告書

全球家用醫療設備市場及技術:新興市場的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on Emerging Markets

價格 : US $ 3900

出版日期 : 2012年03月

對全球家用醫療設備市場及技術:金磚四國的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on BRIC Countries

價格 : US $ 3900

出版日期 : 2012年03月

全球家用醫療設備市場及技術:日本市場的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on Japan

價格 : US $ 3900

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!